Ken Shimokawa

Ken Shimokawa

Geen lopende functies
Consumer Services
Health Technology
Finance

Profiel

Dr. Ken Shimokawa is Senior Investment Director at Astellas Venture Management LLC.
Prior to joining AVM in March 2011, Dr. Shimokawa served as an Associate Director at Department of Licensing & Alliances, Astellas Pharma Inc since October 2010.
He was involved M&A of Japanese Biotech Company, a license-in deal opportunity as well as evaluation of a couple of license-in opportunities.
During 2006-2010, he served as a Global Project Leader for CNS and bone therapeutic area at Project Management, Development, Astellas Pharma Inc. He brought “Bonoteo” for osteoporosis drug in Japanese market, as well as staged up a couple of compounds to P2/3, P1 and P0 in US/EU/JP.
Prior to the GPL, Dr. Shimokawa served as a medicinal and combinatorial chemist to synthesize number of compounds for various therapeutic areas, especially for CNS, Pain and Cardiovascular.
Dr. Shimokawa received a Ph.D.
in Organic Chemistry from the University of Pennsylvania in 1995.

Eerdere bekende functies van Ken Shimokawa

BedrijvenFunctieEinde
Director of Investments 31-03-2014
ASTELLAS PHARMA INC. Corporate Officer/Principal -
Ervaring van Ken Shimokawa in detail bekijken

Opleiding van Ken Shimokawa

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

94

Eerstegraads connecties

3

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit3

Consumer Services

Health Technology

Finance

  1. Beurs
  2. Insiders
  3. Ken Shimokawa
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU